Trials / Terminated
TerminatedNCT03775473
PROgastrine COlon DEpistage
Dosage of Progastrin in Asymptomatic Person Participating in Colon Cancer Screening
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 260 (actual)
- Sponsor
- ECS-Progastrin SA · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Dosage of progastrin in asymptomatic person participating in colon cancer screening
Detailed description
For anyone who will participate in colon screening at the Princess Grace Hospital of Monaco and who has signed the informed consent document. A blood test will be performed in addition to the screening test to assess the rate of progastrin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | progastrin | PROCODE is an interventional study of category 2 (non-medicinal product), with a minimal risks and restrictions, involving only one blood drawn at the screening of colon cancer. |
Timeline
- Start date
- 2019-02-07
- Primary completion
- 2021-02-05
- Completion
- 2021-12-17
- First posted
- 2018-12-14
- Last updated
- 2022-01-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03775473. Inclusion in this directory is not an endorsement.